Início
Explorar
nav.journalClub
Tendências
Mais
synapse
⌘+K
Idioma
Português
Research Paper | Synapse
March 3, 2026
Safety and efficacy of VMAT2 inhibitors in Huntington Disease: A systematic review
AB
Ava Baghaei
Loma Linda University
AZ
Ali Zaredhavani
ZH
Zahra Hashempour
See all
Key Points
Safety and efficacy evaluations reveal positive outcomes with VMAT2 inhibitors in Huntington Disease.
The systematic review incorporates various studies, highlighting efficacy metrics and safety profiles.
Observational analysis across multiple clinical contexts provides insights on VMAT2 inhibitors' impact on disease symptoms.
Supports the need for further investigation of VMAT2 inhibitors to enhance treatment options for Huntington Disease.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Baghaei et al. (Thu,) studied this question.
synapsesocial.com/papers/69a75c3ac6e9836116a24ded
https://doi.org/https://doi.org/10.1016/j.parkreldis.2026.108209